Founded by Adam Salamon in 2019, Pression develops cardiovascular medical devices, led by the Wave PRO™—a compact, automated external counterpulsation system for adults with drug-refractory chronic stable angina. Its calf-only, pulse-synchronized design brings a quieter, more portable alternative to bulky legacy ECP systems, with setup taking just a few minutes. The FDA-cleared system is designed for outpatient, cardiac-rehabilitation, and community-care settings.
FDA 510(k) Clearance
certification